Matches in Wikidata for { <http://www.wikidata.org/entity/Q57109267> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q57109267 description "article scientifique publié en 2018" @default.
- Q57109267 description "article" @default.
- Q57109267 description "im Oktober 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q57109267 description "wetenschappelijk artikel" @default.
- Q57109267 description "наукова стаття, опублікована в жовтні 2018" @default.
- Q57109267 description "հոդված" @default.
- Q57109267 name "Clinical Development of Darolutamide: A Novel Androgen Receptor Antagonist for the Treatment of Prostate Cancer" @default.
- Q57109267 name "Clinical Development of Darolutamide: A Novel Androgen Receptor Antagonist for the Treatment of Prostate Cancer" @default.
- Q57109267 type Item @default.
- Q57109267 label "Clinical Development of Darolutamide: A Novel Androgen Receptor Antagonist for the Treatment of Prostate Cancer" @default.
- Q57109267 label "Clinical Development of Darolutamide: A Novel Androgen Receptor Antagonist for the Treatment of Prostate Cancer" @default.
- Q57109267 prefLabel "Clinical Development of Darolutamide: A Novel Androgen Receptor Antagonist for the Treatment of Prostate Cancer" @default.
- Q57109267 prefLabel "Clinical Development of Darolutamide: A Novel Androgen Receptor Antagonist for the Treatment of Prostate Cancer" @default.
- Q57109267 P1433 Q57109267-FA8C2C9C-D109-4CBA-A5EF-F7DC62FB27DA @default.
- Q57109267 P1476 Q57109267-16CB117E-52AE-4B7F-A283-40BD989D5A65 @default.
- Q57109267 P2093 Q57109267-49BE546D-BC87-4F28-ACCE-A7F5146AE4B2 @default.
- Q57109267 P2093 Q57109267-5BC4D100-E2D4-4C7C-94C1-5B7215A0A1A0 @default.
- Q57109267 P2093 Q57109267-D382CAFC-2071-4A7A-A6A2-84B4F81CB4F5 @default.
- Q57109267 P304 Q57109267-26D3E5FD-D55B-4AB4-B1EA-54AC4EFF4663 @default.
- Q57109267 P31 Q57109267-15FBD1EA-E566-4231-A7D4-B95FF678B243 @default.
- Q57109267 P356 Q57109267-30ADFBBC-6E5C-4BE9-8167-1E33CCFF07EE @default.
- Q57109267 P407 Q57109267-26EB2117-9AB9-45C8-88C8-99C50D094F7B @default.
- Q57109267 P433 Q57109267-60E22C78-07A9-45A1-B504-2923F35F0A49 @default.
- Q57109267 P478 Q57109267-7911D1F0-5479-49E2-A4BC-AC3263966471 @default.
- Q57109267 P50 Q57109267-99409959-59FD-4613-800A-9DB25929B173 @default.
- Q57109267 P577 Q57109267-F3E81C8E-2655-4D4A-8D06-D92AF6AD72A0 @default.
- Q57109267 P698 Q57109267-292A1B86-54C2-4ED7-AE22-6A094977861B @default.
- Q57109267 P921 Q57109267-B352F118-448D-459B-8734-43ADFCA2C443 @default.
- Q57109267 P356 J.CLGC.2018.07.017 @default.
- Q57109267 P698 30197098 @default.
- Q57109267 P1433 Q332266 @default.
- Q57109267 P1476 "Clinical Development of Darolutamide: A Novel Androgen Receptor Antagonist for the Treatment of Prostate Cancer" @default.
- Q57109267 P2093 "Bertrand Tombal" @default.
- Q57109267 P2093 "Karim Fizazi" @default.
- Q57109267 P2093 "Matthew R Smith" @default.
- Q57109267 P304 "332-340" @default.
- Q57109267 P31 Q13442814 @default.
- Q57109267 P356 "10.1016/J.CLGC.2018.07.017" @default.
- Q57109267 P407 Q1860 @default.
- Q57109267 P433 "5" @default.
- Q57109267 P478 "16" @default.
- Q57109267 P50 Q73569107 @default.
- Q57109267 P577 "2018-07-24T00:00:00Z" @default.
- Q57109267 P698 "30197098" @default.
- Q57109267 P921 Q181257 @default.